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Abstract
Background: IL-6 is a pro-inflammatory cytokine that signals via binding to a soluble or membrane bound
receptor, while nitric oxide (NO), an oxidative stress molecule, diffuses through the cell membrane without a
receptor. Both mediators signal through different mechanisms, yet they are dependent on NFB. We proposed that
both mediators are co-induced and co-regulated in inflamed mammary epithelial cells.
Methods: SCp2 mammary epithelial cells were treated with bacterial endotoxin (ET) for different time periods and
analyzed for induction of IL-6 secretion and NO production by ELISA and Griess reaction, respectively. The expression
of IL-6 and induced NO synthase (iNOS) was assayed by real time PCR and/or western immunoblots, and the activation
of NFB was assayed by immunobinding assay. To investigate the role of mammary cell microenvironment (cell-
substratum or interaction of mammary epithelial cell types; critical to mammary development, function, and disease)
in modulation of the inflammatory response, SCp2 cells were cultured with or without extracellular matrix (EHS) or in
coculture with their myoepithelial counterpart (SCg6), and assayed for ET-induced IL-6 and NO.
Results: Endotoxin induced NFB activation at 1 h after ET application. IL-6 secretion and NO production were induced,
but with unexpected delay in expression of mRNA for iNOS compared to IL-6.N F B/p65 activation was transient but
NFB/p50 activation persisted longer. Selective inhibition of NFB activation by Wedelolactone reduced ET-induced
expression of IL-6 mRNA and protein but not iNOS mRNA or NO production, suggesting differences in IL-6 and iNOS
regulation via NFB. SCp2 cells in coculture with SCg6 but not in presence of EHS dramatically induced IL-6 secretion even
in the absence of ET. ET-induced NO production was blunted in SCp2/SCg6 cocultures compared to that in SCp2 alone.
Conclusions: The differential regulation of IL-6 and iNOS together with the differential activation of different NFB
dimers suggest that IL-6 and iNOS are regulated by different NFB dimers, and differentially regulated by the
microenvironment of epithelial cells. The understanding of innate immune responses and inflammation in epithelia
and linkage thereof is crucial for understanding the link between chronic inflammation and cancer in epithelial
tissues such as the mammary gland.
Background
Epithelial cells form the first line of contact with patho-
gens and are capable of initiating and orchestrating
t h ei n n a t ei m m u n er e s p o n s ea g a i n s te x t e r n a li n s u l t s[ 1 ] .
However, a clear understanding of the regulation of
inflammatory respondents and the role of the microenvir-
onment in such regulation are still missing. Mammary
epithelial cells, unlike other epithelial cells such as intest-
inal or skin cells, are well defined for their responsiveness
to signals for proliferation (hormone signal) and differen-
tiation (hormone and extracellular matrix signals) in the
different stages of development of the mammary gland [2].
However, these epithelial cells are poorly understood
for their responses to dedifferentiation signals from
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whether inflammatory responses of the mammary epithe-
lium are modulated by developmental stage or cell micro-
environment, despite the suggested link of chronic
inflammation in epithelia to eventual development of can-
cer therein [3].
The functional mammary epithelium is comprised of a
monolayer of SCp2 secretory epithelial cells open to the
alveolar lumen and surrounded by a layer of contractile
myoepithelial SCg6 cells [4]. The ratio of SCp2 to SCg6
cells increases across development and differentiation of
the mammary gland. SCp2 secretory epithelial cells in
culture respond to exogenous extracellular matrix
(ECM) or intercellular interactions (co-culture with
myoepithelial counterpart SCg6) in the presence of lac-
togenic hormones, by forming cell clusters and induc-
tion of b-casein expression [4,5], thus mimicking the
differentiation and normal function of mammary epithe-
lial cells in vivo wherein the two cell types organize to
form the bilayered secretory epithelium of the mammary
gland. SCp2 cells are responsive to ET by activation of
the cytosolic transcription factor NFB, by secretion of
inflammatory cytokines such as IL-6 and TNFa,a n db y
reverting to a non-differentiated state depicted by a
downregulation of b-casein as well as other differentia-
tion markers [6,7].
The mammalian NFB family is comprised of five sub-
units: p65 (RelA), RelB, c-Rel, p50/p105 (NFB1) and
p52/p100 (NFB 2 )t h a tc o m b i n ei nd i f f e r e n th o m oa n d
hetero dimers to form active NFB. NFBi sf o u n di n a c -
tive in the cytosol due to binding to inhibitory kappa B
(IB). Upon stimulation, IB kinase (IKK) phosphorylates
IB and labels it for ubiquitin-dependent degradation,
thereby releasing activated NFB which then translocates
to the nucleus to activate target genes [8]. Recent studies
have suggested NFB to be the missing link between
inflammation and cancer since it plays a critical role not
only during inflammation but also in regulating cell
cycle, cell differentiation and other normal functions of
the cell [9]. Induced inflammation in the absence of
immune cells activates NFBt oi n d u c ea na r r a yo f
inflammatory respondents such as cyclooxygenase-2
(COX-2), matrix metalloproteinases, inflammatory cyto-
kines (IL-6, TNF-alpha, etc.), and iNOS/NO production.
IL-6 is a multifunctional cytokine produced by
i m m u n ec e l l sa sw e l la sn o n - i m m u n ec e l l ss u c ha s
endothelial, fibroblast and epithelial cells, and is often a
marker of acute or chronic inflammation in clinical
diagnostic assays [10] and found to be critical for cell
survival and development of certain cancers [11].
Nitric oxide (NO) is a pleiotropic inflammatory mar-
ker produced by the conversion of L-arginine to L-
citrulline via three different types of nitric oxide
synthase (NOS) [12]. Neuronal NOS (nNOS or NOS-1)
and endothelial NOS (eNOS or NOS-3) are constitu-
tively expressed in neuronal and endothelial cells,
respectively; while the induced NOS (iNOS or NOS-2)
is induced by inflammatory stimuli such as endotoxin
(ET) and cytokines such as interferon gamma (IFN-g)
and IL-1b in a variety of cell types, including epithelial
cells, and produces high concentrations of NO [13]. The
function of NO varies from a potent vasodilator and
neurotransmitter to inducer of pathogen death and tis-
sue damage depending on its concentration in the tissue
[14]. However, the role of NO in epithelial inflammation
is poorly defined and subject to multiple interpretations
of its causal effects.
In addition to their involvement in the inflammatory
response, IL-6 and NO also may affect epithelial cell
development and function through cell regulation (IL-6)
[15] and intervention in cell signaling (NO) [16], with
potential for different effects at different stages of mam-
mary gland development. Therefore, studying the regu-
lation of these inflammatory markers and their common
regulator (NFB) in a differentiation-competent and
microenvironment responsive mammary epithelial sys-
tem allows investigation of the response of specific
epithelial cell types to external inflammatory stimuli
under different conditions (growth, differentiation, and
acute or chronic inflammation) which model those of
their parent epithelial tissues, and in the absence of
immune cells. The understanding of such innate
immune responses of epithelia and the linkage thereof
to chronic inflammation is crucial for understanding the
link between chronic inflammation and cancer in
epithelial tissues.
The focus of this study was to investigate the regula-
tion and coordination of IL-6 and iNOS by ET-induced
NFB activation in mammary epithelial cells, and
whether such inflammatory responses are modulated by
the cell microenvironment in order to further under-
stand inflammation and inflammation-associated cell
transformation in epithelial cells.
Methods
Cell lines and materials
Mouse mammary epithelial cells SCp2 and SCg6 were
kindly provided by Dr. Pierre Desprez, (Geraldine Brush
Cancer Research Institute; San Francisco, CA). Bovine
insulin, ovine prolactin, hydrocortisone, endotoxin (ET,
as Salmonella typhosa lipopolysaccharide >500,000 EU
(ET units)/mg), and dimethyl sulfoxide (DMSO) were
purchased from Sigma (St. Louis, MO). Englebreth-
Holm-Swarm (EHS)-Matrix growth-factor-reduced BD
Matrigel™ (a commercially available extracellular matrix,
ECM) was purchased from BD Biosciences (Bedford, MA).
Complete™ protease inhibitor tablets were purchased from
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was purchased from EMD Biosciences (La Jolla, CA). Tet-
ramethyl benzidine (TMB) peroxidase substrate was pur-
chased from BioFX Laboratories (Owings Mills, MD).
HRP conjugated anti-rabbit and anti-mouse IgG and
enhanced chemiluminescence reagent (ECL) were pur-
chased from General Electric (GE) Healthcare (Buckin-
ghamshire, UK).
Cell culture
Low passage number (13 to 15) SCp2 cells were used
throughout. Cells were maintained in growth medium
(5% FBS-GM) comprised of DMEM/F12 containing 5%
fetal bovine serum (FBS), insulin (5 μg/ml) and gentami-
cin (50 μg/ml) at 37°C in a humidified atmosphere (95%
Air; 5% CO2).
ET-induced inflammation in SCp2 mouse mammary
secretory-epithelial cells
To assay for the inflammatory responses of differentiat-
ing mammary cells, SCp2 cells were plated on plastic in
5% FBS-GM. Twenty four hours later, cells were induced
to differentiate by adding differentiation medium (0%
FBS-DM) comprised of DMEM/F12, gentamicin (50 μg/
ml), lactogenic hormones (insulin (5 μg/ml), prolactin
(3 μg/ml), and hydrocortisone (1 μg/ml)) lacking FBS but
supplemented with 0 or 1.5% (v/v) exogenous extracellu-
lar matrix (Matrigel™ (EHS)). A stock solution of ET was
prepared at 1 mg/ml in 0% FBS-DM. Inflammation was
induced by application of a non-toxic dose of ET (10 μg/
ml) in 1% FBS-DM 24 h after inducing differentiation.
Samples were harvested at 0, 1, 3, 6, 12, 24, and 48 h
after ET addition. The collected medium was supplemen-
ted with Complete™ protease inhibitor and stored at
- 8 0 ° Cf o rl a t e ra n a l y s i s .C e lls were immediately washed
and processed for RNA extraction or nuclear and cytoso-
lic protein extraction. To assay for b-casein expression,
cultures were left in differentiation medium for 7 days
before harvesting the RNA. Reverse transcribed polymer-
ase chain reaction amplification (RT-PCR) was used to
assay for b-casein expression in differentiated SCp2 cells
using the following primer set: forward (F) = 5’-
GTGGCCCTTGCTCTTGCAAG-3’; reverse (R) = 5’-
AGTCTGAGGAAAAGCCTGAAC-3’ [17].
SCp2/SCg6 co-culture system
SCg6 cells were seeded on plastic at 4 × 10
4 cells/cm
2 in
5% FBS-GM for 24 h, then SCp2 cells were seeded on
top. The co-cultured cells were shifted to differentiation
medium for 24 h before inducing inflammation by addi-
tion of ET (10 μg/ml in 1% FBS-DM). Wells of either
SCg6 or SCp2 (both at 4 × 10
4 cells/cm
2) alone plated
on plastic were used as controls for the SCp2-SCg6 co-
culture response to ET treatment.
Inhibition of NFB activation by Wedelolactone, a
selective inhibitor of IKKa and IKKb
Wedelolactone (7-Methoxy-5, 11, 12 -trihydroxy-coume-
stan), the natural anti-inflammatory agent found in her-
bal medicines from Eclipta alba, is a selective and
irreversible inhibitor of IKKa and IKKb kinase activity
(IC50 = 10 μM) that inhibits NFB-mediated gene tran-
scription by blocking the phosphorylation and degrada-
tion of IBa [18], with no effect on the activities of p38
MAPK or Akt (per the provider; EMD Biosciences).
Wedelolactone (5 mg/ml in DMSO) was added at 10
μM to the cells in 1% FBS DM for 1 h prior to addition
of ET.
Immunoassay of Interleukin-6
To measure IL-6 secretion in response to ET in SCp2
cells, medium collected at various times post-ET treat-
ment was assayed by enzyme-linked immunosorbent
assay (ELISA) for IL-6 (DuoSet kit; R&D Systems Inc,
Minneapolis, MN) according to the manufacturer’s pro-
tocol. Samples were assayed in duplicate and data is
represented as the average pg IL-6/ml of three experi-
ments ± standard error of the mean (SEM).
Griess reaction assay of NO for NOS activity
The analysis of NO was accomplished by the Griess
assay that measures nitrite (the stable spontaneous oxi-
dation product of NO) using a Griess Reagent Kit
(Molecular Probes, Eugene, OR) according to the manu-
facturer’s protocol. Samples were assayed in duplicate
and data is represented as the average concentration of
NO2
- of three experiments ± SEM (μM ± SEM).
RNA extraction, reverse-transcription and quantitative
real time polymerase chain reaction analysis
Total RNA was harvested from cells using Qiagen RNeasy
kits (Qiagen, Valencia, CA) according to the manufac-
turer’s protocol. One microgram of total RNA was treated
with DNAse I (Promega, Madison, WI) before synthesizing
cDNA using the Promega reverse transcription system
(Promega). Quantitative real time PCR (qPCR) was per-
formed using Qiagen Hot start SyBR Green PCR master
mix (Qiagen, Valencia, CA) for each of IL-6 (NM_031168,
F: 5’-GTTCTCTGGGAAATCGTGGA-3’,R :5 ’-GGAAAT
TGGGGTAGGAAGGA-3’), iNOS (NM_010927, F: 5’-
CCCTTCCGAAGTTTCTGGCAGCAGC-3’,R :5 ’-GGCT
GTCAGAGCCTCGTGGCTTTGG-3’) [19], nNOS (NM_
008712), and eNOS (NM_008713) target genes and glycer-
aldehyde-3-phosphate dehydrogenase (GAPDH) (BC094
037, F: 5’-ACCACAGTCCATGCCATCAC-3’,R :
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gene. SybrGreen fluorescence of amplified products was
quantified with an MJ Research Opticon 2 reader (BioRad,
Hercules, CA) relative to an appropriate standard curve
from autonomous qPCR assay reactions. Primer pairs were
either adopted from the literature or designed using Pri-
mer_3 primer design software [21] and synthesized by
Operon Biotechnologies Inc (Huntsville, AL), with ampli-
fied products therefrom authenticated by sequencing. Each
sample was analyzed in triplicate qPCR reactions with the
average quantity for each gene of interest from triplicate
PCR reactions normalized against the average quantity for
the reference gene (GAPDH) from triplicate PCR reactions.
The results of qPCR analysis are presented as the average
amount of each gene relative to GAPDH ± SEM.
Intracellular protein isolation
Total proteins were extracted by scraping SCp2 cells in
lysis buffer (10 mM Tris-HCl pH 7.5, 150 mM NaCl, 1%
v/v Triton X) supplemented immediately before use by
addition of 0.5% sodium orthovandate and 40 μlo f
Complete™ protease inhibitor solution (1 tablet/2 ml
deionized water per manufacturer’s instructions). Sepa-
rate nuclear and cytosolic proteins were selectively
extracted (Nuclear Extract kit; Active Motif, Carlsbad,
CA) according to the manufacturer’s protocol.
Western immunoblot analysis
Total or cytosolic proteins were resolved by SDS-polya-
crylamide gel electrophoresis (SDS-PAGE), blotted onto
polyvinylidene fluoride (PVDF, General Electric (GE);
Buckinghamshire, UK) transfer membrane, and probed
for iNOS (Santa Cruz), phospho-eNOS (ser1177 or
Thr495) (cell Signaling Technology), IBa (Abcam),
pIBa (phospho S32+S36) (Abcam), or b-actin (Sigma).
Total protein extracts of primary bovine aortic endothe-
lial cells (BAEC) or rat brain lysates (Cell Signaling Tech-
nology) were used as positive controls. Densitometric
analyses were performed using NIH image J (NIH).
Immunobinding assay for NFB activation
NFB activation in nuclear proteins was determined
using the NFB family Trans-AM NFB binding assay
kit (Active Motif, Carlsbad, CA) according to the manu-
facturer’s protocol. Positive and negative controls were
assayed simultaneously to verify response specificity.
Samples were assayed in duplicate, with results shown
as the average of absorbance (A690) ± standard devia-
tion (SD).
Immunodot blot cytokine protein array analysis
RayBio™ Mouse Cytokine ArrayI was purchased from
RayBiotech, Inc (Norcross, GA). Conditioned medium
collected from control and ET-treated SCp2 cells at 1,
3, 6, and 12 h post-ET was incubated with the cytokine
array membranes according to RayBiotech protocols.
Signal was detected using a provided ECL Plus detec-
tion system (Amersham Phramacia Biotech) and
exposed to Kodak x-omat AR film (Kodak; New Haven,
CT).
Statistical analysis
Significant differences between different groups were
determined using Proc Mixed analysis of SAS 9.1 (SAS
Institute Inc., Cary, NC). For each set of experiments
studying the effect of ET alone or ET in the presence or
absence of Wedelolactone (IKK inhibitor), serum and
ECM on IL-6, iNOS/NO and/or NFB, the statistical
analysis included time post ET treatment, treatment
(ET, Wedelolactone, ECM, or ET and Wedelolactone),
and time by treatment interactions. The effect of treat-
ment within each time point was tested using the slice
option by time. Results of two experiments were
expressed as mean ± SEM, and significance was defined
by p < 0.05, unless noted otherwise.
Results
ET induced IL-6 and NO in SCp2 mouse mammary
epithelial cells
To compare the temporal pattern of ET-induced IL-6
secretion and NO production, the medium of ET trea-
t e dS C p 2c e l l sw a sa n a l y z e df o rI L - 6a n dN Oc o n c e n -
trations at sequential time points. IL-6 secretion was
significantly increased by 3 h post-ET and continued to
increase until it plateaued at 12 h and after (Figure 1A).
A slight but not statistically significant increase of IL-6
secreted protein was observed over time even in the
absence of ET (Figure 1A). In contrast, nitrite concen-
trations, reflecting NOS activity, showed no increase
until 6 h post-ET treatment but increased continually
thereafter for the duration of the experiment (Figure
1B). In the absence of ET, basal nitrite levels changed
little over time (Figure 1B). IL-6 mRNA expression was
sharply induced as early as 1 h after ET treatment, and
peaked at 3 h before decreasing to control concentra-
tions by 6 h post-ET treatment (Figure 1C). A subse-
quent slow rise in the expression of IL-6 mRNA was
also observed with time between 12 and 24 h post-ET
in both ET-treated and control cells (Figure 1C). In
contrast, iNOS mRNA expression increased sharply
from near zero at 1 h post-ET to peak at 3 h post-ET
with maximum expression 10-15 fold higher than that
for induction of IL-6 mRNA relative to GAPDH at the
same time point. By 6 h post-ET, iNOS mRNA expres-
sion had decreased sharply and was maintained near
control concentrations for the remainder of the experi-
ment (Figure 1D).
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Figure 1 Temporal pattern of ET-induced IL-6 secretion, NO production, and IL-6 and iNOS mRNA expression. Subconfluent SCp2 cells
were treated with ET (0 or 10 μg/ml) in 1% FBS DM as described in Methods. (A) IL-6 secretion assayed by ELISA and (B) NO production assayed
by Griess reaction. RNA harvested at each time point were analyzed by RT-qPCR for ET-induced (C) IL-6 mRNA and (D) iNOS mRNA and
quantified relative to GAPDH mRNA for each. Solid-line represents the results for control non ET-treated cells; while dashed-line represents the
results for ET-treated cells. Each experiment was performed at least 3 times. Samples were assayed separately in duplicate analyses by either
ELISA or Griess reaction assay. For RT-qPCR, each sample was analyzed in triplicate RT-qPCR reactions. Data represents the average of samples
from 3 experiments ± SEM with (*) denoting significant differences from non-ET control within each time point (p < 0.05).
Maalouf et al. Journal of Inflammation 2010, 7:58
http://www.journal-inflammation.com/content/7/1/58
Page 5 of 17Immunoblot analysis of the protein expression of the
three isoforms of NOS and phosphorylation status in
mammary cells
Western immunoblotting analysis showed no expression
of iNOS protein in SCp2 cell in the absence of ET; how-
ever, a target 130 kDa band appeared maximally at 3 h
through 6 h post-ET treatment before declining from 12
through 24 h to disappear by 48 h (Figure 2A & 2B).
An inexplicable lower, but apparently non-specific uni-
dentified band at ~120 kDa appeared in all samples
assayed independent of ET treatment, including the
bovine aortic endothelial cells (BAEC) protein extract
used as positive control (Figure 2A). Immunoblots for
the other two forms of NOS in SCp2 cells showed no
detectable nNOS expression (data not shown), and only
a basal expression of eNOS which showed no modula-
tion by ET treatment (data not shown) and showed no
evidence of activation based on lack of phosphorylation
of amino acid residues serine 1177 or threonine 495
except in the BAEC positive control (data not shown).
ET activation of NFB subunits p65 & p50 in SCp2 cells
We defined the temporal pattern of NFB activation by
ET, and compared that pattern to the temporal pattern
of ET-induced IL-6 and iNOS mRNA expression and NO formation. The nuclear proteins isolated from ET-treated
SCp2 cells were analyzed for the different forms of NFB
using the NFB family binding assay. Of the 5 subunits
of NFB tested, two forms, p65 and p50, increased their
binding activity in response to ET compared to the basal
binding activity in SCp2 cell nuclear protein extracts. Fig-
ure 3A shows an abrupt increase in ET-induced p65
activity that peaked by 1 h post-ET treatment, decreased
thereafter to 1/3 and 1/4 the peak level at 3 h and 6 h,
respectively, but was well above the level seen in non-ET
treated cells at the corresponding time. In contrast, p50
activity was increased to maximum by 1 h post-ET and
declined only slightly by 6 h post-ET (Figure 3B).
Wedelolactone inhibits ET-induced IKK phosphorylation
SCp2 cells were treated with Wedelolactone for 1 h prior
to ET addition, and isolated proteins were assayed by wes-
tern immunoblots for phosphorylated IB1hp o s t - E T .
Phosphorylation of IB increased 3 fold in response to ET
treatment (Figure 4A & 4B). However, treatment of SCp2
cells with Wedelolactone prior to ET addition reduced
phosphorylated IB in a concentration dependent manner
(Figure 4B). Immunoblots of total IBs h o w e dn oc l e a r
decrease in IB protein (Figure 4C) except at the highest
Wedelolactone concentration (Figure 4A & 4C).
Wedelolactone inhibits ET-induced IL-6 but not iNOS
mRNA expression
Wedelolactone (10 μM) reduced IL-6 mRNA expression
by ~70% (p < 0.05) at 3 h after ET treatment compared
A.
B.
Figure 2 ET-induced expression of iNOS protein in SCp2 cells.
Western immunoblots of total cellular protein extracts were probed
for (A) iNOS with expected molecular weight of 130 kDa (specific
bands indicated by arrow). (B) Densitometric analysis was done
using NIH Image J program. The fold change of the intensity of the
130 KDa band relative to that of b-actin housekeeping gene
expression was plotted over time post-ET treatment. Bovine aortic
endothelial cell (BAEC) total protein extract were included as
positive control (+C) for iNOS. Equal loading of proteins was verified
by probing for 42 kDa b-actin. Each lane represents one sample at a
particular time point. This experiment was repeated three
independent times and densitometric analysis shown was
performed on one of the blots as representative of the magnitude
of change noted across the three experiments.
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Figure 3 ET induces binding activity of NFBp 6 5a n dp 5 0i n
SCp2 cells. SCp2 cells were treated as described in Methods with 0
or 10 μg of ET per ml in 1% FBS-DM for 0, 1, 3, and 6 h. Isolated
nuclear proteins of control (0 μg ET) and ET-treated (10 μg ET) SCp2
cells were analyzed for (A) NFB p65 or (B) NFB p50 binding
activities by immunobinding assays, with relative binding activity
shown as A690 above blank. Solid-line and closed symbol represent
the results of control non ET-treated samples, while dashed-line and
open symbol represent the results of samples from ET-treated cells.
This experiment was performed at least twice. Data represents the
average for duplicate samples ± SD of a representative experiment.
(*) denotes significant difference among treatment within each time
point (p < 0.05).
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lactone (Figure 5A). However, expression of ET-induced
IL-6 mRNA was incompletely inhibited by 10 μMW e d e -
lolactone as shown by its significant elevation above con-
trol at 1 and 3 h post-ET (Figure 5A). By 6 h, ET-induced
IL-6 mRNA expression had decreased to non-ET control
levels (at 0 h) independent of Wedelolactone treatment
(Figure 5A). In contrast, Wedelolactone did not inhibit
iNOS mRNA expression in SCp2 cells at 3 h post-ET
(Figure 5B). By 6 h after ET treatment, iNOS mRNA
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Figure 4 Wedelolactone inhibits ET-induced IKK phosphorylation. (A) Nuclear protein of SCp2 cells treated with various doses of the IKKa/
IKKb inhibitor, Wedelolactone (W), were harvested and assayed for phosphorylated and total IB proteins. Equal loading of proteins was verified
by probing for 42 kDa b-actin. (B & C) Densitometric analysis was calculated using NIH Image J program. The intensity of each of the phospho
IB (B) and IB (C) bands were compared to those of b-actin housekeeping gene expression. Each lane represents one sample at a particular
time point. This experiment was repeated two independent times. The same trend of change appeared in both plots, but the blot and
densitometric analysis shown represent the stronger change of the two.
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Figure 5 Wedelolactone inhibits ET-induced IL-6 but not iNOS. Total RNA was extracted from SCp2 cells treated with 0 or 10 μM
Wedelolactone (W) in DMSO (vehicle) for 1 h before ET treatment at 0 or 10 μg ET/ml for 0, 1, 3, and 6 h. 1 μg total RNA were reverse
transcribed then amplified by real-time qPCR for ET induced (A) IL-6 and (B) iNOS mRNA. Amplified mRNA concentrations of IL-6 and iNOS were
normalized to those of constitutive GAPDH mRNA. The medium was collected at 1, 3, 6, 12, and 24 h post-ET, and assayed for induced (C) IL-6
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Page 8 of 17decreased to near pre-ET control levels but remained sig-
nificantly higher than control levels (Figure 5B) indepen-
dent of Wedelolactone pre-treatment.
Despite strong inhibition of IL-6 mRNA expression
(~70% inhibition) by Wedelolactone (Figure 5A), ET-
induced IL-6 protein secretion showed inhibition of (38%
( p<0 . 0 5 ) )o n l ya t1 2hp o s t - E Tc o m p a r e dt oc o n t r o l
cells treated with ET alone in the absence of Wedelolac-
tone (Figure 5C). In contrast, ET-induced NO production
was not affected by Wedelolactone pretreatment (Figure
5D), consistent with the lack of effect of Wedelolactone
on ET-induced iNOS mRNA expression (Figure 5B).
Effects of exogenous EHS on ET-induced IL-6 secretion
and NO production in SCp2 cells
To confirm that SCp2 cells are differentiation compe-
tent as shown by others [4,5], cells were grown under
growth (plastic substrate without lactogenic hormones)
(Figure 6A) or differentiation conditions (EHS and lacto-
genic hormones). Differentiated SCp2 cells were marked
by their reorganization into cell clusters (Figure 6B) and
upregulation of the milk protein b-casein, assayed for by
RT-PCR (Figure 6C).
Next, we tested the effect of EHS addition on ET-
induced inflammation in mammary secretory epithelial
cells. SCp2 cells were grown and treated with ET as
described in Materials and Methods. The medium was
c o l l e c t e da t0 ,1 ,3 ,6 ,1 2 ,2 4 ,a n d4 8hp o s tE Tt r e a t -
ment and was assayed for IL-6 secretion (Figure 6D),
and NO production (Figure 6E). In order to compensate
for any difference in cell growth rate on EHS vs. plastic,
the results of secreted IL-6 and NO production were
presented relative to cell number. SCp2 cells showed
similar temporal patterns and concentrations of IL-6
secretion in response to ET treatment in the absence or
presence of EHS (Figure 6D). Similarly, the temporal
pattern of ET-induced NO production was not modu-
lated by EHS addition; however, the magnitude of NO
production tended to be greater, though not statistically
significant, in cells supplemented with EHS (Figure 6E).
EHS addition had no effect on ET-induced IL-6 and
iNOS mRNA expression (data not shown).
Effect of mixed SCp2 and SCg6 cells on inflammatory
response to ET
Both secretory (SCp2) and myoepithelial (SCg6) mam-
mary cell types are important in the formation and dif-
ferentiation of the bi-layered secretory epithelium in the
mammary gland [17,22]. Also, the lactating mammary
gland is notably sensitive to microbial ET during intra-
mammary infection [15]. Therefore, we investigated the
effect of SCp2 and SCg6 interaction on ET-induced
inflammation. Surprisingly, the coculture of SCp2 and
SCg6 cells in the absence of ET induced a dramatic
increase (p < 0.05) in IL-6 secretion (Figure 7A) that
was significantly higher than basal or ET-induced IL-6
secretion in either SCp2 or SCg6 alone (Figure 7A). The
concentration of secreted IL-6 remained dramatically
higher in medium from SCp2:Scg6 cocultures (Figure
7B) even if normalized to cell number; thus the dramati-
cally increased IL-6 induction in cocultures was not due
to higher cell seeding density or growth rate in cocul-
tures vs. individual cell cultures. In contrast, sponta-
neous NO production was modest in SCp2:SCg6
cocultures (1:1 ratio) in the absence of ET-treatment
( F i g u r e7 C ) .U p o nE Tt r e a t m e n t ,N Op r o d u c t i o n
increased but the total concentration was only half the
level of NO produced in ET-treated SCp2 cells on plas-
tic (Figure 7C). SCp2 cells alone showed the expected
induction of NO by ET, while SCg6 showed little NO
production in response to ET (Figure 7C).
Effect of SCp2:SCg6 cell ratio in coculture vs. SCp2 cell
plating density on plastic on ET-induced IL-6 secretion
and NO production
We studied the effect of ratio of myoepithelial: secretory
epithelial mammary cell types in coculture to simulate
their estimated ratio in the mammary epithelium across
development and functional state. Different cell seeding
densities of SCp2 cells (1, 2, 4, and 8 × 10
4 cells/cm
2)
were plated either on plastic or on a confluent SCg6 cell
monolayer and treated with ET as described in Meth-
ods. In the absence of ET, SCp2 cells plated on plastic
secreted concentrations of IL-6 that increased modestly
with increased cell seeding density (Figure 8A). ET
treatment induced a significant 3 to 4 fold increase in
IL-6 secretion above basal levels, especially at the two
highest SCp2 cell densities (4 × 10
4 and 8 × 10
4 cell/
cm
2) (Figure 8A). In SCp2:SCg6 cocultures (Figure 8B),
the basal IL-6 secretion (without ET) was dramatically
higher and increased progressively with increasing plat-
ing density of SCp2 cells on a confluent SCg6 mono-
layer (Figure 8B). A significant (p < 0.05) increase in
secreted IL-6 was observed upon treatment with ET for
24 h. However, the 2-3 fold relative increase in ET-
induced IL-6 secretion over basal IL-6 secretion in the
absence of ET found at lower ratios of SCp2:SCg6
cocultures was decreased at higher SCp2 plating densi-
ties. Basal IL-6 secretion was 5 to 9 fold higher (p <
0.05) for SCp2 cells in cocultures (Figure 8B) than for
those seeded on plastic (Figure 8A). However, ET
induced a 3 to 4-fold higher (p < 0.05) IL-6 secretion in
SCp2:SCg6 cell cocultures (Figure 8B) than SCp2 cells
on plastic (Figure 8A), regardless of cell plating number.
SCg6 alone in the absence of SCp2 showed a 5 fold
increase (p < 0.05) in IL-6 secretion in response to ET
in comparison to non-ET treated cells (Figure 8B, 0
SCp2 plating density).
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Page 9 of 17In contrast to IL-6 secretion, basal NO production
was low in SCp2 cells plated either on plastic (Figure
8C) or in coculture (Figure 8D). ET treatment induced a
very significant increase in NO production (p < 0.05)
only in SCp2 cells seeded on plastic at 4 × 10
4 cell/cm
2
(same plating density as previous experiments) or higher
(Figure 8C). ET-induced NO production was significant
but much lower in SCp2 cells plated on SCg6 mono-
layer (Figure 8D). Though basal levels of NO were not
significantly different in SCp2 plated on plastic or in
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Figure 6 The effect of EHS on SCp2 cell differentiation and their response to ET. Phase contrast photomicrographs (40×, Bar = 50 μm) of
SCp2 cells (plated at 4 × 10
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experiment.
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Page 10 of 17coculture with SCg6 for all SCp2 cell plating numbers,
ET-induced NO levels were significantly (p < 0.05) atte-
nuated in SCp2:SCg6 cocultures (Figure 8D) compared
to ET-induced NO levels in SCp2 cells on plastic but
only for higher SCp2 plating cell numbers of 4 × 10
4
and 8 × 10
4 cell/cm
2 cell (Figure 8C). In contrast to
SCp2 cells, and as previously found (Figure 7B), SCg6
cells alone showed little induction of NO in response to
ET (Figure 8D, 0 SCp2 plating density).
ET induces an array of cytokines in SCp2 mouse
mammary cells
Culture medium collected from SCp2 cells at 1, 3, 6 and
12 h after ET treatment was analyzed for inflammatory
cytokine secretion using RayBio Mouse cytokine Anti-
body Array I (Fig, 9A & 9B). Of the 22 cytokines
assayed, only IL-6 (Figure 9C) and granulocyte colony
stimulating factor (GCSF) (Figure 9D) increased signifi-
cantly starting at 3 h post-ET treatment and remained
elevated up to 12 h post-ET. Though RANTES appeared
to increase slowly starting at 6 h and peaked at 12 h
post-ET (Figure 9A) the differences were not statistically
significant.
Discussion
Epithelial cells are important in initiating an innate
immune response against external pathogens in tissues
such as lung, intestine and mammary gland [1]. Recep-
tors to external pathogens, NFB activation [1], and
cytokine secretion together with production of reactive
oxygen and nitrogen species production are critical for
local elimination of the pathogen independent of
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Page 11 of 17immune cells as well as for activation and recruitment
of immune cells to the site of infection [23].
This study investigated the co-regulation of IL-6
secretion and NO production by ET in SCp2 mouse
mammary secretory epithelial cell cultures, with predic-
tion of their co-induction by ET as known for immune
cells [24]. However, contrary to expectation, they
showed different temporal patterns of response to ET in
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Page 12 of 17Figure 9 Mouse cytokine protein array of SCp2 cells following treatment with ET. Subconfluent SCp2 cells were treated with ET (0 or 10
μg/ml) in 1% FBS DM for 1, 3, 6, and 12 h, and medium collected at each time point was assayed for different inflammatory cytokines (A) by
the RayBio Mouse Cytokine Antibody Array I. (B) Layout of the mouse cytokine protein array on the membrane. Abbreviations POS = positive
control, NEG = negative control. GCSF = granulocyte colony stimulating factor, GM-CSF = granulocyte macrophage colony stimulating factor, IL
= interleukin, IFN-g = interferon gamma, MCP = monocyte chemotactic protein, RANTES = regulated on activation, normal T expressed and
secreted, SCF = stem cell factor, sTNFR = soluble tumor necrosis factor a receptor, TNFa = tumor necrosis factor alpha, VEGF-vascular
endothelial growth factor. Densitometric analysis of (C) IL-6 and (D) GCSF proteins secreted in response to ET at different time points was
calculated using NIH Image J program. Error bars denote the standard deviation (SD) between duplicate of a representative dot blot.
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Page 13 of 17SCp2 mouse mammary secretory epithelial cells. The
delayed response of NO relative to IL-6 was observed
for both the secreted proteins and their mRNA expres-
sion (Figure 1). Although the observed delay in NO pro-
duction might be partly explained by the time required
for iNOS to synthesize NO and the rate of the conver-
sion of the latter to a more stable nitrite (NO2
-)f o r m ,
the observed delay in expression of iNOS mRNA which
was not induced before 3 h post-ET (Figure 1D) com-
pared to that of IL-6 mRNA induced at 1 h post-
ET (Figure 1C), indicates differences in the regulation of
expression of IL-6 and iNOS as ET-induced
respondents.
Treatment of SCp2 cells with different doses of exo-
genous mouse recombinant IL-6 protein at doses (0.1, 1,
and 10 nM) representing respectively 1/10, 1, and 10 ×
the levels of secreted IL-6 protein found in the medium
of ET-treated SCp2 cells, did not induce expression of
iNOS when applied alone in the absence of ET (data
not shown), suggesting that the expression of iNOS
mRNA was induced in response to ET alone and not in
response to IL-6, and thus the delay in iNOS expression
is due to a different control mechanism than that of
IL-6.
We also investigated the effect of ET on the binding
activity of p65 and p50, the major NFB subunit types
known to be involved in ET signaling via the rapid
MyD88-dependent pathway (reviewed in [25]). The
results in Figure 4 showed a rapid activation of both
p65 and p50 at 1 h post-ET; however, while p65 activa-
tion was transient, activation of p50 was sustained
through 6 h post-ET. Although others described the
activation of p65/p50 NFB via the rapid MyD88-
dependent pathway involving IKK-dependent IBp h o s -
phorylation and ubiquitin-dependent degradation
(reviewed in [25]), other reports suggested that the regu-
lation of p50 might involve additional pathways other
than IB degradation [26]. In any case, the difference in
p65 and p50 activation suggests that the difference
between ET-induced IL-6 and iNOS mRNA expression
might involve different pathways of NFB activation;
one that is IB degradation-dependent while the other
is not; therefore, inhibition of the IKK complex that
phosphorylates IB and labels it for degradation would
modulate only the IB dependent NFB activation path-
way and its target genes.
Consistent with the difference in regulation of both
IL-6 and iNOS mRNA expression, Wedelolactone treat-
ment inhibited only ET-induced IL-6 mRNA expression
but not that of iNOS. These results suggest that while
IL-6 mRNA expression is likely dependent on the rapid
MyD88-dependent NFB activation pathway, iNOS
mRNA expression likely involves the delayed MyD88-
independent NFB activation pathway. Kawai et al
(2000) showed that ET-induced IL-6 production was
impaired in MyD88
-/- mouse macrophages [27], while
Schilling et al (2002) reported that expression of iNOS
but not that of IL-6 mRNA was enhanced by ET-
induced IFNg in mouse macrophages [28]. In our study,
IFNg was not significantly induced in SCp2 cells treated
with ET (Figure 9). Hence, these studies, together with
our results in epithelial cells suggest that the differential
regulation of ET-induced IL-6 and iNOS by NFB
involves different kinetics and alternate pathways of
NFB activation for each whereby IL-6 mRNA expres-
sion is likely induced by the rapid MyD88-dependent
activation pathway of NFB but iNOS mRNA expres-
sion might involve the slower MyD88-independent acti-
vation pathway of NFB. Furthermore, the observed
d e l a yi ne x p r e s s i o no fi N O Sc o m p a r e dt ot h a to fI L - 6
mRNA coincides with reports describing a role for IL-6
in acute inflammation and in the transition to chronic
inflammation [10], in contrast to NO that was proposed
to limit inflammation [29].
Though iNOS is the induced form of NOS upregu-
lated in response to ET in the SCp2 secretory mammary
cells used in this study, other studies described a possi-
bility for induction of mRNA expression of supposedly
constitutive eNOS and nNOS or the regulation of eNOS
by phosphorylation [12]. Others also showed that the
constitutive activity of eNOS can be modulated by phos-
phorylation of amino acid residues serine 1177 (Ser
1177) and/or threonine 495 (Thr 495) in rat heart and
endothelial cells [30]. In this study, we were unable to
show conclusive qPCR amplification or modulation of
protein expression of either eNOS or nNOS in response
to ET (data not shown). Thus, our data suggest that ET-
induced NO in SCp2 mammary epithelial cells is due
mainly to iNOS expression and activity.
Moreover, by global immunodot-blot assay for ET-
induced cytokines, we found that SCp2 mammary
secretory epithelial cells are capable of producing
inflammatory cytokines and chemokines similar to
immune cells. The cytokines that were significantly
upregulated in response to ET from immunoblot analy-
sis were GCSF and IL-6 (Figure 9). GCSF is involved in
monocyte chemotaxis as well as cell differentiation, sug-
gesting that mammary secretory epithelial cells, likely to
be the first cells in contact with infecting bacteria of the
mammary gland, play an important role in innate
immunity and in recruiting immune cells and orches-
trating their function. IFNg was present but was not
significantly induced in ET-treated SCp2 cells.
The present study also demonstrates that ET-induced
IL-6 secretion and NO production are differentially
regulated by the microenvironment of SCp2 cells in cul-
ture. Upon induction of cell differentiation either by
addition of EHS or by SCp2:SCg6 co-culture, we
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Page 14 of 17investigated the role of EHS and SCp2-SCg6 interaction
on IL-6 secretion and NO production in SCp2 cells
alone or in SCg6 co-cultures with or without ET-
induced inflammation. While EHS had no effect on ET-
induced IL-6 secretion (Figure 6D), SCp2 cells cultured
in the presence of EHS showed a slight but significant
increase (~25%) in NO production in response to ET
compared to SCp2 cells on plastic (Figure 6E). Despite
differential regulation of the secreted products, ET-
induced iNOS mRNA had similar temporal patterns of
expression regardless of substratum (data not shown).
Whether the observed increase in NO in the medium
was due in part to increased chemical stability of NO in
the presence of EHS was not investigated. Similarly, IL-
6 mRNA expression patterns in response to ET were
not affected by EHS (data not shown).
However, there was a strong and unexpected sponta-
neous induction of IL-6 when SCp2 cells were cultured
on a monolayer of SCg6 cells; IL-6 concentrations
increased dramatically to several-fold higher than for
either SCp2 or SCg6 cells alone, independent of ET
treatment and cell number (Figure 7A & 7B). The con-
centration of IL-6 in control co-culture cells was higher
than the sum of IL-6 secreted in both control SCp2 and
SCg6 cells cultured independently, showing a strong
synergistic effect of SCg6-SCp2 interaction on IL-6
s e c r e t i o ne v e ni nt h ea b s e n c eo fE T( F i g u r e7 A&7 B ) .
These results are interesting in light of reports in the lit-
erature of a role for IL-6 in cell-cell association [31]. In
marked contrast, growth of SCp2 cells on an SCg6
monolayer seemed to reduce ET-induced NO response
although NO basal levels were not affected (Figure 7C),
confirming that the previously shown differential regula-
tion of IL-6 and NO extends to SCp2 cells in co-culture.
Despite the intriguing effect of SCp2:SCg6 co-culture on
spontaneous and induced inflammation, any inference
as to how the effects of SCp2:SCg6 interaction would
relate to the mammary gland in vivo requires caution
since SCg6 cells were described as a malignant mam-
mary cell line having lost their responsiveness to ECM
regulation and were shown to induce tumors when
injected into athymic nude mice [32]. Whether SCg6
cells result in the tumor or induce transformation in
epithelial cells is not yet clear; however, the induction of
a spontaneous inflammatory response in SCp2 cocul-
tured with SCg6 may be related to the predicate of
chronic inflammation leading to cancer in epithelial tis-
sues [3]. Our findings become even more interesting in
light of studies by Talhouk et al (2008) and Gudjonsson
et al (2002). The first study underlines the importance
of heterocellular interactions between SCp2 and SCg6
cells in enhancing expression of connexins and of cate-
nin cell protein interactions as expected for more com-
plete SCp2 cell and epithelial differentiation in vitro
[22], while the second emphasizes the importance of
myoepithelial cells in maintaining epithelial cell polarity
and the bilayered structure of epithelial cells and myoe-
pithelial cells in the normal mammary tissue [33].
The ratio of secretory epithelial to myoepithelial cells
varies in ductular vs. alveolar mammary epithelia [34],
with the ratio of secretory epithelial to myoepithelial
cells low in duct tissue and higher (>1) in the alveolus
with dominance therein by the monolayer of secretory
epithelial cells surrounded by a discontinuous layer of
myoepithelial cells [34]. Therefore, we varied the ratio
of SCp2 to SCg6 cells in the co-culture by plating SCp2
cells on a monolayer of SCg6 cells at SCp2:SCg6 cell
plating ratios of 1:4, 1:2, 1:1, and 2:1. SCp2:SCg6 co-
culture induced a dramatic 5 to 9-fold increase in basal
levels of IL-6 secretion in control non-ET treated cells
compared to that in SCp2 or SCg6 cells alone on plastic
(Figure 8A vs. 8B). The net increase of IL-6 secretion
from ET-induction was independent of cell number in
SCp2:SCg6 co-cultures, indicating that cell-cell interac-
tion affected only basal secretion of IL-6 proteins but
not that induced by ET (Figure 8B). In contrast to IL-6,
while basal NO levels varied little in SCp2 cells on plas-
tic (Figure 8C), ET-induced NO production increased
significantly (by 15 to 20-fold) only at high SCp2 cell
plating density (4 and 8 × 10
4 cell/cm
2)( F i g u r e8 D )
compared to basal non-ET treated levels; emphasizing
again the differential regulation of IL-6 and NO in
mammary epithelial cells. It remains intriguing but
unknown whether or how the cellular ratios and influ-
ence thereof on regulation of the inflammatory
responses in mammary epithelial cells as shown here
might relate to the in vivo ratios and associations of
secretory epithelial to myoepithelial cells within the
quiescent adult human mammary gland and its elevated
risk of developing breast cancer [35,36].
Conclusions
In conclusion, we have shown that ET induces IL-6 and
iNOS but not eNOS or nNOS mRNA expression in
SCp2 mammary epithelial cells. ET-induced IL-6 and
iNOS mRNA expression occurs likely via different regu-
latory mechanisms as shown by a delay in the temporal
pattern of ET-induced iNOS mRNA expression and NO
production compared to that of IL-6 mRNA expression
and protein secretion. The inhibition of ET-induced IL-
6 but not iNOS mRNA expression by the IKK inhibitor
Wedelolactone suggests that the different regulation of
IL-6 and iNOS by ET likely involves rapid (IL-6) vs.
slow (iNOS) NFB activation pathways. Moreover, cell-
ECM and cell-cell interactions between the two resident
cell types of the mammary epithelium differentially
modulate ET-induced IL-6 and NO inflammatory
responses in the absence of immune cells. Intriguingly,
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of IL-6 but not NO production. These results suggest
that the microenvironment context of the inflamed
epithelial cell is important for understanding the regula-
tion of inflammation and the link between inflammation
and cancer.
Moreover, our study along with previous studies from
our group using similar approaches in the mammary
epithelial cell system, emphasize that inflammation in
mammary epithelial cells would involve a set of early
inflammatory respondents (IL-6, TNFa,a n dN G F[ 3 7 ]
and unpublished data), and late respondents (iNOS, NO,
and MMPs [37,38]) induced in temporal sequences that
may ultimately lead to disruption of cell-substratum
interactions and tissue function to eventually lead to dis-
ease. Though all of these inflammatory markers are
regulated by NFB, the studies recorded here show that
they likely are not regulated by the same NFB subunits,
or NFB activating machinery. Therefore, understanding
of the innate immune response of epithelia particularly
for its regulation and coordination, and linkage thereof
to immune responses will be crucial for understanding
the link between chronic inflammation and cancer in
epithelial tissues.
T h ed i f f e r e n c ei nt h er e g u l a t i o no ft w oN F B
mediated inflammatory respondents (IL-6 and NO)
described in this study in addition to the temporal regu-
lation of NFB for specific responses [39] and for NFB
activation by different inflammatory stimuli [40] demon-
strates the importance of timing in orchestrating the
activation of inflammatory respondents and regulation
of inflammation. The ability of SCp2 mammary secre-
tory epithelial cells to respond to inflammatory stimula-
tion as well as to changes in their extracellular matrix
environment and interactions between the two cell types
comprising the mammary epithelium provides an inter-
esting model to further investigate the difference in tem-
poral regulation of inflammatory respondents and their
modulation by the cell differentiation state and by inter-
action of epithelial cell types in the absence of immune
cells.
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